Gensight Biologics (France) Buy Hold or Sell Recommendation
| SIGHT Stock | EUR 0.37 0.05 15.62% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Gensight Biologics SA is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Gensight Biologics SA within the specified time frame.
Check out Gensight Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Gensight and provide practical buy, sell, or hold advice based on investors' constraints. Gensight Biologics SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Gensight |
Execute Gensight Biologics Buy or Sell Advice
The Gensight recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Gensight Biologics SA. Macroaxis does not own or have any residual interests in Gensight Biologics SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Gensight Biologics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Gensight Biologics Trading Alerts and Improvement Suggestions
| Gensight Biologics has some characteristics of a very speculative penny stock | |
| Gensight Biologics had very high historical volatility over the last 90 days | |
| The company reported the revenue of 5.28 M. Net Loss for the year was (28.62 M) with profit before overhead, payroll, taxes, and interest of 7.71 M. | |
| Gensight Biologics SA has accumulated about 44.29 M in cash with (17.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders |
Gensight Biologics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Gensight analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Gensight analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Gensight Biologics Returns Distribution Density
The distribution of Gensight Biologics' historical returns is an attempt to chart the uncertainty of Gensight Biologics' future price movements. The chart of the probability distribution of Gensight Biologics daily returns describes the distribution of returns around its average expected value. We use Gensight Biologics SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Gensight Biologics returns is essential to provide solid investment advice for Gensight Biologics.
| Mean Return | -0.01 | Value At Risk | -6.06 | Potential Upside | 8.57 | Standard Deviation | 4.72 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Gensight Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Gensight Biologics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Gensight Biologics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Gensight Biologics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Gensight stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | -0.01 | |
σ | Overall volatility | 4.71 | |
Ir | Information ratio | -0.03 |
Gensight Biologics Volatility Alert
Gensight Biologics SA exhibits very low volatility with skewness of 0.73 and kurtosis of 1.06. Gensight Biologics SA is a potential penny stock. Although Gensight Biologics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Gensight Biologics SA. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Gensight instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Gensight Biologics Fundamentals Vs Peers
Comparing Gensight Biologics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Gensight Biologics' direct or indirect competition across all of the common fundamentals between Gensight Biologics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Gensight Biologics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Gensight Biologics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Gensight Biologics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Gensight Biologics to competition |
| Fundamentals | Gensight Biologics | Peer Average |
| Return On Equity | -1.72 | -0.31 |
| Return On Asset | -0.39 | -0.14 |
| Operating Margin | (6.59) % | (5.51) % |
| Current Valuation | 150.19 M | 16.62 B |
| Shares Outstanding | 46.16 M | 571.82 M |
| Shares Owned By Insiders | 12.75 % | 10.09 % |
| Shares Owned By Institutions | 35.65 % | 39.21 % |
| Price To Book | 50.99 X | 9.51 X |
| Price To Sales | 33.81 X | 11.42 X |
| Revenue | 5.28 M | 9.43 B |
| Gross Profit | 7.71 M | 27.38 B |
| EBITDA | (25.52 M) | 3.9 B |
| Net Income | (28.62 M) | 570.98 M |
| Cash And Equivalents | 44.29 M | 2.7 B |
| Cash Per Share | 1.06 X | 5.01 X |
| Total Debt | 12.1 M | 5.32 B |
| Debt To Equity | 14.40 % | 48.70 % |
| Current Ratio | 3.65 X | 2.16 X |
| Book Value Per Share | 0.07 X | 1.93 K |
| Cash Flow From Operations | (17.14 M) | 971.22 M |
| Earnings Per Share | (0.68) X | 3.12 X |
| Target Price | 9.8 | |
| Number Of Employees | 44 | 18.84 K |
| Beta | 2.16 | -0.15 |
| Market Capitalization | 144.58 M | 19.03 B |
| Total Asset | 56.65 M | 29.47 B |
| Z Score | 6.6 | 8.72 |
| Net Asset | 56.65 M |
Gensight Biologics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Gensight . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Gensight Biologics Buy or Sell Advice
When is the right time to buy or sell Gensight Biologics SA? Buying financial instruments such as Gensight Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Gensight Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Theme ETFs Thematic Idea Now
Theme ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Theme ETFs theme has 483 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Theme ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Gensight Stock Analysis
When running Gensight Biologics' price analysis, check to measure Gensight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gensight Biologics is operating at the current time. Most of Gensight Biologics' value examination focuses on studying past and present price action to predict the probability of Gensight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gensight Biologics' price. Additionally, you may evaluate how the addition of Gensight Biologics to your portfolios can decrease your overall portfolio volatility.